tirzepatide kidney damage improves outcomes in T2DM with increased CV risk Next-generation therapeutics for diabetic kidney

Zepbound is marketed separately from Mounjaro, which contains the same active ingredient (tirzepatide) but is FDA-approved specifically for type 2 diabetes management

This review examines the intersection of semaglutide therapy and MNT, aiming to collate and summarise the available evidence to support practical, evidence-based dietary recommendations for patients receiving semaglutide

This therapy highlights the role of amylin receptor agonists in addressing unmet needs beyond incretin therapies

Domestic News A pharmacy was fined $1mm for compounding weight loss injectables in uninspected settings

Lyophilization ensures maximum stability with a shelf life of 24+ months when stored at -20C

Tirzepatide may be considered in women with PCOS and obesity when substantial weight loss is the primary therapeutic target